Greg D. Aunan
Chief Accounting Officer
Common Stock
- Reported value
- $321.4K
- Reported price
- $16.07 / share
NEOGENOMICS INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Chief Accounting Officer
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Accounting Officer | Common StockSale | 20,000$16.07 / share | $321.4K | Aug 4Filed Aug 6 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 5,307$11.10 / share | $58.91K | Jun 15Filed Jun 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 5,307$11.29 / share | $59.92K | Jun 9Filed Jun 11 · 2d later | SEC filing |
NeoGenomics, Inc. - Common Stock (NEO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.